Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from DermTech

Millennials And Gen Xers Are Unaware Of Nonmelanoma, Found In A New Study

New research suggests four in five millennials and Gen Xers are mindful about the sun with mixed results in use of sunscreen.

Can DermTech Recover From Its 85% Tumble?

Can DermTech Recover From Its 85% Tumble?

The skin diagnostics company has a promising technology platform, but growth has stalled.

Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Looking Into DermTech's Return On Capital Employed

Benzinga Pro data, DermTech (NASDAQ:DMTK) reported Q1 sales of $3.72 million. Earnings fell to a loss of $30.11 million, resulting in a 15.56% decrease from last quarter.

DermTech: Q1 Earnings Insights

DermTech (NASDAQ:DMTK) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DermTech missed estimated earnings by 13.48%, reporting an EPS of $-1.01 versus an estimate of $-0.89.

DermTech's Earnings Outlook

DermTech (NASDAQ:DMTK) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that DermTech will report an earnings per share (EPS) of $-0.89.

DermTech: Q4 Earnings Insights

DermTech (NASDAQ:DMTK) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DermTech missed estimated earnings by 20.55%, reporting an EPS of $-0.88 versus an estimate of $-0.73.

inkl

Read news from The Economist, FT, and more,
with one subscription

Earnings Outlook For DermTech

Earnings Outlook For DermTech

DermTech (NASDAQ:DMTK) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate that DermTech will report an earnings per share (EPS) of $-0.73.

Organisations

Arista Networks

Petrobras Brasileiro

Lincoln National

GoodRx Holdings

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play